Wieliczka, Poland

Maciej Pawłowski

This inventor holds 1 USPTO granted patent. Top assignee: Adamed Sp. Z O.o.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maciej Pawłowski. Retrieved from https://idiyas.com/inventor/maciej-pawłowski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maciej Pawłowski: Innovator in CNS Treatment

Introduction

Maciej Pawłowski is a notable inventor based in Wieliczka, Poland. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of central nervous system (CNS) diseases. His innovative work has the potential to impact many lives positively.

Latest Patents

Maciej Pawłowski holds a patent for "Arylosulfonamides for the treatment of CNS diseases." This patent includes arylsulphonamide derivatives of formula (I) and pharmaceutically acceptable salts thereof. The compounds developed by Pawłowski may be useful for the treatment and/or prevention of disorders of the central nervous system. He has 1 patent to his name.

Career Highlights

Pawłowski is currently employed at Adamed Sp. z o.o., a company known for its focus on innovative pharmaceutical solutions. His work at Adamed has allowed him to further his research and development efforts in the field of CNS treatments.

Collaborations

Throughout his career, Maciej has collaborated with talented individuals such as Marcin Kołaczkowski and Piotr Kowalski. These collaborations have enriched his research and contributed to the advancement of his projects.

Conclusion

Maciej Pawłowski is a dedicated inventor whose work in CNS treatment showcases his commitment to improving healthcare. His innovative patents and collaborations highlight his significant contributions to the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…